Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background GLP-1 agonists, including liraglutide, have emerged as effective therapies for type 2 diabetes (DM) and obesity. Here, we attempted to delineate how liraglutide, at doses approved for DM, may impact circulating hormones influencing energy homeostasis in diabetics. Basic Procedures Using a randomized, placebo-controlled, double-blind, cross-over trial of 20 patients with type 2 diabetes, we examined the effects of liraglutide as compared to placebo on fasting levels of circulating hormones important to energy homeostasis, including leptin, ghrelin, PYY, and GIP. After 17 days (0.6 mg for 7 days, 1.2 mg for 7 days and 1.8 mg for 3 days) of treatment, we also studied changes in fMRI responses to food cues. Main Findings By design, to avoid any confounding by weight changes, subjects were studied for 17 days, i.e. before body weight changed. Participants on liraglutide had significantly increased GLP-1 levels (p<0.001), decreased percent change in leptin levels (p<0.01) and increased GIP levels (p<0.03) in comparison to placebo treated subjects. Whole brain regressions of functional activity in response to food cues reveal that increased GIP levels were associated with deactivation of the attention- and reward-related insula. Decreases in leptin levels were associated with activations in the reward-related midbrain, precuneus, and dorsolateral prefrontal cortex (DLPFC), and sensorimotor-related motor cortex and with deactivations in the attention-related parietal cortex and the cognitive control-related thalamus and pre-SMA. Principal Conclusions We demonstrate herein short-term changes to circulating levels of GIP and leptin in response to GLP-1 agonist liraglutide therapy. These findings suggest that liraglutide may alter the circulating levels of hormones important in energy homeostasis that, in turn, influence CNS perception of food cues. This could possibly lead to compensatory changes in energy homeostasis that would over time limit the efficacy of liraglutide to decrease body weight. These novel findings, which, pointing to the potential advantages of combination therapies, may have therapeutic implications, will need to be confirmed by larger and longer-term trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Food reward: brain substrates of wanting and liking
Berridge, K. C. (1996) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00033-b · Cited by 1,901
Recombinant human leptin in women with hypothalamic amenorrhea
Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040388 · Cited by 908
Self-citationNeural Systems for Visual Orienting and Their Relationships to Spatial Working Memory
Corbetta, M., Kincade, J. M., & Shulman, G. L. (2002) · Journal of Cognitive Neuroscience · doi:10.1162/089892902317362029 · Cited by 698
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., et al. (2014) · Diabetes · doi:10.2337/db14-0302 · Cited by 602
van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.162 · Cited by 537
Hunter, K., & Hölscher, C. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-33 · Cited by 504
Neuroimaging and obesity: current knowledge and future directions
Carnell, S., Gibson, C., Benson, L., Ochner, C. N., & Geliebter, A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00927.x · Cited by 441
GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
van Bloemendaal, L., IJzerman, R. G., ten Kulve, J. S., Barkhof, F., Konrad, R. J., Drent, M. L., Veltman, D. J., & Diamant, M. (2014) · Diabetes · doi:10.2337/db14-0849 · Cited by 427
Research works printed but not linked: 54
- Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 10.1038/nature05485 · DOI · Paper page
- Aronis, 2014, Potential cardioprotective action of glp-1: from bench to bedside, Metabolism, 63, 979, 10.1016/j.metabol.2014.05.009 · DOI
- Vilsboll, 2007, Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes, Diabetes Care, 30, 1608, 10.2337/dc06-2593 · DOI · Paper page
- Sisley, 2014, Neuronal glp1r mediates liraglutide's anorectic but not glucose-lowering effect, J Clin Invest, 124, 2456, 10.1172/JCI72434 · DOI · Paper page
- Farr, 2014, Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure, J Clin Endocrinol Metab, 99, E2529, 10.1210/jc.2014-2774 · DOI · Paper page
- Konturek, 2003, Brain-gut axis in pancreatic secretion and appetite control, J Physiol Pharmacol, 54, 293
- Konturek, 2003, Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion, Eur J Pharmacol, 481, 1, 10.1016/j.ejphar.2003.08.042 · DOI · Paper page
- Orr, 2005, Dietary influences on peripheral hormones regulating energy intake: potential applications for weight management, J Am Diet Assoc, 105, 1115, 10.1016/j.jada.2005.04.005 · DOI
- Farr, 2016, Diabetologia
- Harder, 2004, The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes, Diabetes Care, 27, 1915, 10.2337/diacare.27.8.1915 · DOI · Paper page
- Chan, 2003, The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men, J Clin Invest, 111, 1409, 10.1172/JCI200317490 · doi:10.1172/jci200317490 · Paper page
- Larsen, 2001, Systemic administration of the long-acting glp-1 derivative nn2211 induces lasting and reversible weight loss in both normal and obese rats, Diabetes, 50, 2530, 10.2337/diabetes.50.11.2530 · DOI · Paper page
- Clemmensen, 2014, Glp-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet, Diabetes, 63, 1422, 10.2337/db13-1609 · DOI · Paper page
- Al-Barazanji, 2000, Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) zucker rats, Obes Res, 8, 317, 10.1038/oby.2000.38 · DOI · Paper page
- Aziz, 2005, Hyperglycemia after protein ingestion concurrent with injection of a glp-1 receptor agonist in rats: A possible role for dietary peptides, Am J Physiol Regul Integr Comp Physiol, 289, R688, 10.1152/ajpregu.00850.2004 · DOI
- He, 2010, Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice, PLoS One, 5, e14205, 10.1371/journal.pone.0014205 · DOI · Paper page
- Patel, 2013, Co-agonist of glucagon and glp-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese c57 mice, Can J Physiol Pharmacol, 91, 1009, 10.1139/cjpp-2013-0189 · DOI
- Patel, 2013, Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (−4 db/db)*, J Diabetes, 5, 163, 10.1111/j.1753-0407.2012.00227.x · DOI
- Pocai, 2009, Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice, Diabetes, 58, 2258, 10.2337/db09-0278 · DOI · Paper page
- Su, 2008, Boc5, a non-peptidic glucagon-like peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice, PLoS One, 3, e2892, 10.1371/journal.pone.0002892 · DOI · Paper page
- Claret, 2004, S 23521 decreases food intake and body weight gain in diet-induced obese rats, Obes Res, 12, 1596, 10.1038/oby.2004.199 · DOI
- Liu, 2014, The anorexic effect of ex4/fc through glp-1 receptor activation in high-fat diet fed mice, Acta Biochim Biophys Sin (Shanghai), 46, 675, 10.1093/abbs/gmu044 · DOI
- Malendowicz, 2003, Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats, Int J Mol Med, 11, 763
- Perez-Tilve, 2007, Exendin-4 potently decreases ghrelin levels in fasting rats, Diabetes, 56, 143, 10.2337/db05-0996 · DOI · Paper page
- Daousi, 2013, Acute peripheral administration of synthetic human glp-1 (7-36 amide) decreases circulating il-6 in obese patients with type 2 diabetes mellitus: A potential role for glp-1 in modulation of the diabetic pro-inflammatory state?, Regul Pept, 183, 54, 10.1016/j.regpep.2013.03.004 · DOI
- Diaz-Soto, 2014, Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with type 2 diabetes: A prospective study, Diabetes Res Clin Pract, 104, 92, 10.1016/j.diabres.2014.01.019 · DOI
- Drewes, 1997, A liquid mixed meal or exogenous glucagon-like peptide 1 (glp-1) do not alter plasma leptin concentrations in healthy volunteers, Acta Diabetol, 34, 230, 10.1007/s005920050079 · DOI
- Gutzwiller, 1999, Glucagon-like peptide-1: A potent regulator of food intake in humans, Gut, 44, 81, 10.1136/gut.44.1.81 · DOI · Paper page
- Shalev, 1997, Absence of short-term effects of glucagon-like peptide-1 and of hyperglycemia on plasma leptin levels in man, Metabolism, 46, 723, 10.1016/S0026-0495(97)90112-8 · DOI
- Wada, 2014, Leptin and its receptors, J Chem Neuroanat, 61–62, 191, 10.1016/j.jchemneu.2014.09.002 · DOI
- Farr, 2015, Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders, Metabolism, 64, 114, 10.1016/j.metabol.2014.07.004 · DOI
- Le, 2006, Less activation of the left dorsolateral prefrontal cortex in response to a meal: A feature of obesity, Am J Clin Nutr, 84, 725, 10.1093/ajcn/84.4.725 · DOI · Paper page
- Le, 2007, Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss, Am J Clin Nutr, 86, 573, 10.1093/ajcn/86.3.573 · DOI
- Rosen, 2015, Functional mri reveals a cognitive control subnetwork supporting long-term memory-guided visual attention, J Vis, 15, 1247, 10.1167/15.12.1247 · doi:10.1167/15.12.1247
- Neale, 2015, Functional activation during the rapid visual information processing task in a middle aged cohort: An fmri study, PLoS One, 10, e0138994, 10.1371/journal.pone.0138994 · DOI · Paper page
- Mason, 2015, Attentional bias predicts increased reward salience and risk taking in bipolar disorder, Biol Psychiatry
- Hosseini, 2015, Reward feedback stimuli elicit high-beta eeg oscillations in human dorsolateral prefrontal cortex, Sci Rep, 5, 13021, 10.1038/srep13021 · DOI
- Irlbacher, 2014, Mechanisms and neuronal networks involved in reactive and proactive cognitive control of interference in working memory, Neurosci Biobehav Rev, 46, 58, 10.1016/j.neubiorev.2014.06.014 · DOI
- Prevosto, 2013, Cognitive control of movement via the cerebellar-recipient thalamus, Front Syst Neurosci, 7, 56, 10.3389/fnsys.2013.00056 · DOI
- Corbetta, 2002, Control of goal-directed and stimulus-driven attention in the brain, Nat Rev Neurosci, 3, 201, 10.1038/nrn755 · DOI · Paper page
- McFadden, 2013, Effects of exercise on resting-state default mode and salience network activity in overweight/obese adults, Neuroreport, 24, 866, 10.1097/WNR.0000000000000013 · DOI · Paper page
- Polania, 2015, The precision of value-based choices depends causally on fronto-parietal phase coupling, Nat Commun, 6, 8090, 10.1038/ncomms9090 · DOI · Paper page
- Deacon, 2011, Physiology of incretins in health and disease, Rev Diabet Stud, 8, 293, 10.1900/RDS.2011.8.293 · DOI · Paper page
- Deacon, 2005, What do we know about the secretion and degradation of incretin hormones?, Regul Pept, 128, 117, 10.1016/j.regpep.2004.06.007 · DOI · Paper page
- El-Ouaghlidi, 2007, The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion, J Clin Endocrinol Metab, 92, 4165, 10.1210/jc.2006-1932 · DOI · Paper page
- Woerle, 2012, The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes, Diabetes, 61, 2349, 10.2337/db11-1701 · DOI · Paper page
- Lund, 2011, The separate and combined impact of the intestinal hormones, gip, glp-1, and glp-2, on glucagon secretion in type 2 diabetes, Am J Physiol Endocrinol Metab, 300, E1038, 10.1152/ajpendo.00665.2010 · DOI · Paper page
- Rolls, 2015, Taste, olfactory, and food reward value processing in the brain, Prog Neurobiol, 127–128, 64, 10.1016/j.pneurobio.2015.03.002 · DOI · Paper page
- Rolls, 2015, Functions of the anterior insula in taste, autonomic, and related functions, Brain Cogn
- Val-Laillet, 2015, Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity, Neuroimage Clin, 8, 1, 10.1016/j.nicl.2015.03.016 · DOI · Paper page
- Wang, 2015, Reward breaks through center-surround inhibition via anterior insula, Hum Brain Mapp, 10.1002/hbm.23004 · DOI
- Wijngaarden, 2015, Obesity is marked by distinct functional connectivity in brain networks involved in food reward and salience, Behav Brain Res, 287, 127, 10.1016/j.bbr.2015.03.016 · DOI
- Nyberg, 2007, Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain, J Neurosci Res, 85, 2099, 10.1002/jnr.21349 · DOI · Paper page
- Kramer, 2015, The impact of chronic liraglutide therapy on glucagon secretion in type 2 diabetes: insight from the libra trial, J Clin Endocrinol Metab, 100, 3702, 10.1210/jc.2015-2725 · DOI · Paper page
Cited by
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
Chakhtoura, M., Haber, R., Ghezzawi, M., Rhayem, C., Tcheroyan, R., & Mantzoros, C. S. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.101882 · Cited by 462
Self-citationUpadhyay, J., Farr, O., Perakakis, N., Ghaly, W., & Mantzoros, C. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.004 · Cited by 375
Self-citationAmbery, P., Parker, V. E., Stumvoll, M., Posch, M. G., Heise, T., Plum-Moerschel, L., Tsai, L.-F., Robertson, D., Jain, M., Petrone, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30726-8 · Cited by 298
Pharmacotherapy of obesity: available medications and drugs under investigation.
Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248
Self-citationBray, J. J. H., Foster‐Davies, H., Salem, A., Hoole, A. L., Obaid, D. R., Halcox, J. P. J., & Stephens, J. W. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14399 · Cited by 194
Metadata
- Authors
- Farr, O. M., Tsoukas, M. A., Triantafyllou, G., Dincer, F., Filippaios, A., Ko, B.-J., & Mantzoros, C. S.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 65
- Issue
- 7
- Pages
- 945-953
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2298314932
- Cited by
- 105
- References
- 24
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Center for Research Resources
- Harvard Catalyst (UL1 RR025758)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (5T32HD052961)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study. https://app.cochat.ai/papers/10.1016/j.metabol.2016.03.009
- The paper
- Farr, O. M., Tsoukas, M. A., Triantafyllou, G., Dincer, F., Filippaios, A., Ko, B.-J., & Mantzoros, C. S. (2016). Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study. Metabolism. https://doi.org/10.1016/j.metabol.2016.03.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.